3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Arthritis, Rheumatoid
13
Spondylitis, Ankylosing
5
Colitis, Ulcerative
4
Psoriasis
3
Crohn Disease
3
Uveal Melanoma
1
Thyroid Carcinoma, Anaplastic
1
Spondylarthritis
1
Sarcoidosis
1
Recurrence
1
Plaque Psoriasis
1
Osteoarthritis
1
Nephrotic Syndrome
1
Nephrosis, Lipoid
1
Mucopolysaccharidosis VI
1
Mucopolysaccharidosis II
1
Mucopolysaccharidosis I
1
Mucopolysaccharidoses
1
Melanoma
1
Macular dystrophy, corneal type 1
1
Kidney Diseases
1
Joint Diseases
1
Inflammatory Bowel Diseases
1
Inflammation
1
Hidradenitis Suppurativa
1
Healthy Adult Male
1
Healthy
1
Glomerulosclerosis, Focal Segmental
1
Dupuytren Contracture
1
Autoimmune Diseases
1
Interventions
Nutrition Assessment
2
Collagenases
2
upadacitinib
1
tocilizumab
1
acetaminophen, aspirin, caffeine drug combination
1
Vaccines
1
Transcutaneous Electric Nerve Stimulation
1
Saline Solution
1
Resistance Training
1
Radiotherapy
1
Omeprazole
1
Naproxen
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Lysine Acetyltransferase 5
1
Holistic Health
1
Herpes Zoster Vaccine
1
Febuxostat
1
Exergaming
1
Exercise Therapy
1
Colchicine
1
Blood Specimen Collection
1
Allopurinol
1
Adalimumab
1
Abatacept
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Arthritis
×
Adalimumab
×
Clear all
NCT00696059
2008-06-12
HURRAH
Hvidovre University Hospital
Phase 4
Completed
52 enrolled